Meta-analysis of overall incidence and risk of ALK inhibitors-induced liver toxicities in advanced non-small-cell lung cancer

AIM: Activation of the anaplastic lymphoma kinase (ALK) gene has been found in several human cancers, including non-small-cell lung cancer (NSCLC). Currently, novel drugs targeting ALK gene have been extensively investigated in NSCLC. However, concerns about ALK inhibitors-induced liver toxicities h...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingjie, Yuan, Zhi, Wang, Qun, Fan, Weijie, Zhang, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344205/
https://www.ncbi.nlm.nih.gov/pubmed/30608384
http://dx.doi.org/10.1097/MD.0000000000013726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344205/
https://www.ncbi.nlm.nih.gov/pubmed/30608384
http://dx.doi.org/10.1097/MD.0000000000013726

Ejemplares similares